Fighting disease with ETFs

anti_mosquito_410The world turned upside down this morning. The Cancun climate change summit has agreed a deal. And Deutsche Bank’s ETF platform, db x-trackers, has launched an ETF that helps fight Aids, tuberculosis and malaria. Now, db x-trackers is a well-known laboratory for new ETF ideas. When I think of it, and I think of it often, I see bubbling beakers of chemicals and wild-haired men in white coats scratching their dome-shaped foreheads as they roll out the latest innovation: Sumatran grass-roofed real estate ETF, Inter-galactic small caps ETF. But fighting Aids, tuberculosis and malaria: surely that’s a bit of a stretch? Apparently not. The new Global Fund Supporters ETF will track the Dow Jones Global Fund 50 Index to Fight AIDS, Tuberculosis and Malaria(SM)(that’s its actual name), launched today on the Frankfurt Stock Exchange. The index tracks the performance of the largest public companies that support the mission of the Global Fund, a global public/private partnership dedicated to attracting and disbursing resources to prevent and treat the three diseases in question. The Global Fund ETF is designed to make the new Global Fund index as investable as possible. db x-trackers’ management revenues for the ETF, after costs, will go towards the Global Fund. “We’ve seen a massive uptake in our ETFs since we launched in 2007,” said Thorsten Michalik, global head of db x-trackers. “With ever increasing numbers of investors embracing the products, and with more of those investors wishing to invest along socially-conscious lines, we are confident that the db x-trackers Global Fund Supporters ETF will be a success.” Professor Michel Kazatchkine, executive director of the Global Fund, said the collaboration between the Global Fund and Deutsche Bank was an example of how innovative financing could both benefit investors and serve humanitarian purposes. “With Deutsche Bank the Global Fund is showing that it is possible to do well and to do good at the same time,” he said. In another, admittedly slightly less exciting development, db x-trackers is abandoning synthetic replication for the first time for this ETF. The Global Fund Supporters ETF uses physical replication to track its index. Fiona Rintoul, editorial director
©2010 funds europe

Executive Interviews

INTERVIEW: Put your money where your mouth is

10 Jun 2016

At Kempen Capital Management, they believe portfolio managers should invest in their own funds. David Stevenson talks to Lars Dijkstra, CIO of the €42 billion manager.

EXECUTIVE INTERVIEW: ‘Volatility is the name of the game’

13 May 2016

Axa Investment Managers chief executive officer, Andrea Rossi, talks to David Stevenson about bringing all his firm’s subsidiaries under one name and the opportunities that a difficult market...


ROUNDTABLE: Beyond the hype

13 Oct 2016

The use of smart beta investing continues to grow. Our panel, made up of both providers and users, discusses what the strategy actually means, how it should be used and the kind of pitfalls that may arise when using this innovative investment technique.

MIFID II ROUNDTABLE: Following the direction of travel

07 Sep 2016

Fund management firms Aberdeen and HSBC Global meet with specialist providers to speak about how the industry is evolving towards MiFID II.